Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gastric cancer: an update.

Manish A Shah1

  • 1Department of Medicine, Gastrointestinal Oncology Service, Memorial Sloan-Kettering Cancer Center and the Weil School of Medicine of Cornell University, 1275 York Avenue, New York, NY 10021, USA. shah1@mskcc.org

Current Oncology Reports
|April 19, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Emerging role of antibody-drug conjugates in gastrointestinal malignancies.

Cancer·2026
Same author

Event-free survival as a surrogate for overall survival in locally advanced esophageal cancer: a correlation analysis of trials assessing definitive chemoradiation therapies.

BMC cancer·2026
Same author

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Whole genome sequencing approach to assess homologous recombination deficiency in a pan-cancer cohort.

Communications medicine·2026
Same author

Phase Ia/b Multicenter Study of BPM31510IV Targeting Mitochondrial Metabolism/Warburg Effect as Monotherapy and Combination Chemotherapy in Solid Tumor Patients.

Cancer research communications·2025
Same author

Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survival.

Pathology, research and practice·2025

Gastric cancer, if advanced, is incurable but manageable with chemotherapy. Targeted therapies are limited, with cytotoxic therapy remaining standard despite a lack of consensus on the optimal regimen.

Area of Science:

  • Oncology
  • Gastroenterology
  • Cancer Biology

Background:

  • Gastric cancer is an aggressive malignancy with limited curative options when metastatic or unresectable.
  • Chemotherapy offers palliative benefits for advanced gastric cancer patients.
  • Despite advances in understanding gastric cancer biology, targeted therapies remain underdeveloped.

Purpose of the Study:

  • To review the pathophysiology and epidemiology of gastric cancer.
  • To discuss current advances in the treatment of gastric cancer.
  • To highlight the limitations in developing targeted therapies.

Main Methods:

  • Review of existing literature on gastric cancer pathophysiology, epidemiology, and treatment.
  • Analysis of current cytotoxic chemotherapy regimens.

Related Experiment Videos

  • Discussion of the challenges in targeted therapy development.

    • Main Results:

    • Cytotoxic chemotherapy is the current standard of care for advanced gastric cancer.
    • While active agents and combinations are known, a definitive reference regimen is lacking.
    • Biologically targeted therapies for gastric cancer have seen limited development.

    Conclusions:

    • Understanding gastric cancer pathophysiology and epidemiology is crucial for treatment advancements.
    • Further research is needed to overcome limitations in developing targeted therapies.
    • Consensus on a standard chemotherapy regimen is needed to optimize palliative care for advanced gastric cancer.